©Reuters. FILE PHOTO: The Procter & Gamble Co. logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, the United States, on June 27, 2018. REUTERS/Brendan McDermid
(Reuters) – Procter & Gamble raised its full-year sales forecast on Wednesday as the consumer goods giant benefits from higher prices and a rebound in demand for cleaning products amid a surge in COVID-19 infections.
Shares of the company rose nearly 2% in premarket trading as strong quarterly sales helped cushion the blow of a stronger-than-predicted increase in annual freight and commodity costs.
Sales of fabric and home care products, including Tide and Mr. Clean, rose 7% in the second quarter as the rapid spread of the Omicron variant coronavirus prompted consumers to buy more cleaning products.
A more intense flu season also boosted organic demand for personal care products by 20%.
This, combined with price increases to offset higher merchandise and freight costs, increased net sales by 6% to $20.95 billion. Analysts had expected $20.34 billion, according to Refinitiv IBES data.
Inflationary pressures are expected to linger for a while longer, P&G's chief financial officer said after the company reported $2.8 billion in losses this year.
P&G also raised its organic revenue growth guidance for fiscal 2022 to 4% to 5% from 2% to 4% and said it would buy back $9 billion to $10 billion of stock, compared to a $7 billion previously expected to $9 billion.
P&G also softened speculation that it might be interested in buying GlaxoSmithKline's (NYSE:) consumer health business, which has attracted interest from European competitor Unilever (NYSE:).
In a CNBC interview, CEO Jon Moeller said he's "very happy with the current portfolio" and sees no need for a major acquisition.
On Saturday, GSK rejected Unilever's $68.4 billion bid for its consumer division, calling it undervalued and saying it would stick to plans for a separate listing of the company later this year.
Disclaimer: Fusion Media would like to remind you that the data contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are provided by market makers rather than exchanges and as such prices may not be accurate and may vary from actual market price meaning prices are indicative and not for trading purposes are suitable. Therefore, Fusion Media accepts no responsibility for any trading loss that you may incur as a result of using this data.
Fusion Media or anyone associated with Fusion Media shall not be liable for any loss or damage arising out of reliance on any information, including data, quotes, charts and buy/sell signals, contained on this website. Please educate yourself fully about the risks and costs associated with trading the financial markets as this is one of the riskiest forms of investment of all.